
|Articles|December 1, 2002
The American Journal of Managed Care
- December 2002
- Volume 8
- Issue 12
Economic Evaluation of Enoxaparin as Prophylaxis Against Venous Thromboembolism in Seriously Ill Medical Patients: A US Perspective
Author(s)Gregory de Lissovoy, PhD, Prasun Subedi, BS
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Reduction in Food Allergies Found After Guideline-Directed Early Peanut Exposure
2
Adding Radioligand Therapy Pluvicto to SOC Cuts Risk of Prostate Cancer Progression or Death 28%, but How Many Doses?
3
FDA Expands Semaglutide Label to Reduce Cardiovascular Risk in Adults With Type 2 Diabetes
4
Counseling Patients With OSA on Side Effects of GLP-1s: Matthew Biszewski, PharmD
5